US employers unexpectedly cut jobs in February and the unemployment rate rose, pointing to lingering fragility in a labor market that was thought to be stabilizing. Nonfarm payrolls fell 92,000 last month, one of the largest declines since the pandemic, after a strong start to the year. While some of the downside was expected in advance, like a temporary dent from striking healthcare workers and a...
US employers unexpectedly cut jobs in February and the unemployment rate rose, pointing to lingering fragility in a labor market that was thought to be stabilizing. Nonfarm payrolls fell 92,000 last month, one of the largest declines since the pandemic, after a strong start to the year. While some of the downside was expected in advance, like a temporary dent from striking healthcare workers and a potential hit from bad weather, a wide array of industries cut jobs in the month. The figures call into question whether the labor market is actually steadying — as Wall Street economists and Federal Reserve officials had hoped — after the worst year for hiring outside of a recession in decades. Bloomberg TV and Radio International Economics & Policy Correspondent Michael McKee joins Bloomberg Businessweek Daily to discuss. McKee speaks with Carol Massar and Tim Stenovec. (Source: Bloomberg)
Sources of Income- dividend or capital distribution. DNY59/E+ via Getty Images Analysis YieldMax TSLA Option Income Strategy ETF ( TSLY ) basically runs a synthetic covered call investment strategy to harvest option premiums in Tesla's options with the expectancy of generating income for investors along with benefiting from gradual appreciation in the shares of Tesla. As we can see, this has under...
Sources of Income- dividend or capital distribution. DNY59/E+ via Getty Images Analysis YieldMax TSLA Option Income Strategy ETF ( TSLY ) basically runs a synthetic covered call investment strategy to harvest option premiums in Tesla's options with the expectancy of generating income for investors along with benefiting from gradual appreciation in the shares of Tesla. As we can see, this has underperformed both Tesla stock ( TSLA ) and S&P500 ( SPY ) ETFs. Basically, any kind of Income based funds focusing on covered call writing are not very efficient way for having an exposure in any underlying. While many people miss this — you are essentially trading away your upside for getting some additional income in terms of call options premiums. Basically, the incremental income is limited to net premium earned, while materially capping the upside if underlying advances significantly over short-period. That, contrary to many, isn't an appropriate compensation to trade away the asymmetric upside for any stock. Return Comparison (SeekingAlpha) The above chart reflects the total return generated by TSLY since inception, compared with the underlying Tesla returns and S&P 500 ETFs. On a total return basis, the TSLY ETF has lagged both its underlying and a simple broad-based ETF. Even without taking into account the economic prospects of Tesla — if you consider it overvalued — then it makes little sense to be exposed to its downside. At the same time, if you believe it offers a compelling value proposition, your upside is nonetheless materially capped in lieu of generating additional income in the form of premiums written. If the stock declines by half, you will lose a broadly similar magnitude (the stock decline minus the call premiums collected). Based on the latest holdings disclosed by the fund , there does not appear to be any Long Put protection on downside. In a nutshell, you are trading away upside while retaining nearly full downside exposure creating a positive expect...
Key Points Novo Nordisk shares look cheap, but execution and management changes weigh on investor confidence. Eli Lilly’s stronger GLP-1 growth and consistency support its premium versus Novo’s conditional value story. 10 stocks we like better than Novo Nordisk › Is Novo Nordisk (NYSE: NVO) a bargain or a value trap as it battles Eli Lilly (NYSE: LLY) for GLP‑1 leadership, execution credibility, a...
Key Points Novo Nordisk shares look cheap, but execution and management changes weigh on investor confidence. Eli Lilly’s stronger GLP-1 growth and consistency support its premium versus Novo’s conditional value story. 10 stocks we like better than Novo Nordisk › Is Novo Nordisk (NYSE: NVO) a bargain or a value trap as it battles Eli Lilly (NYSE: LLY) for GLP‑1 leadership, execution credibility, and premium growth? Watch the video below to see how investors might navigate this high‑stakes rivalry. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » *This video was published on Feb. 24, 2026. Should you buy stock in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $534,817!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,123,912!* Now, it’s worth noting Stock Advisor’s total average return is 964% — a market-crushing outperformance compared to 192% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors. See the 10 stocks » *Stock Advisor returns as of March 6, 2026. Andy Cross has no position in any of the stocks mentioned. Loren Horst has positions in Novo Nordisk. Nicholas Sciple has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. The views ...
4 Takeaways From Top Minnesota Officials' Testimony On State's Massive Fraud Authored by Janice Hisle via The Epoch Times (emphasis ours), Two of Minnesota’s top officials, Gov. Tim Walz and Attorney General Keith Ellison, testified before Congress for more than four hours on March 4 about their state’s multibillion-dollar fraud controversies. (L-R) Minnesota Gov. Tim Walz, Minnesota Attorney Gene...
4 Takeaways From Top Minnesota Officials' Testimony On State's Massive Fraud Authored by Janice Hisle via The Epoch Times (emphasis ours), Two of Minnesota’s top officials, Gov. Tim Walz and Attorney General Keith Ellison, testified before Congress for more than four hours on March 4 about their state’s multibillion-dollar fraud controversies. (L-R) Minnesota Gov. Tim Walz, Minnesota Attorney General Keith Ellison, and Rev. Mariah Tollgaard, are sworn in ahead of their testimony before the House Committee on Oversight and Government Reform on Capitol Hill in Washington on March 4, 2026. Madalina Kilroy/The Epoch Times During the latest hearing on Capitol Hill, Republicans tried to pin down when the two Democratic leaders were alerted to the fraud , why payments continued afterward, and what role politics may have played. Rep. James Comer (R-Ky.) summed up the scandal this way: “ While whistleblowers were silenced, fraudsters got rich .” Comer chairs the House Committee on Oversight and Government Reform, which has now held two hearings on Minnesota fraud cases this year. 🚨 JUST IN: House Oversight Chair James Comer affirms whistleblowers testified UNDER OATH that they spent YEARS warning Tim Walz and Keith Ellison about rampant fraud IT’S TIME FOR WALZ AND ELLISON TO BE JAILED. US taxpayers are SICK AND TIRED of politicians stealing from them pic.twitter.com/n6K2lwalBi — Javier Salazar (@ded_fx) March 5, 2026 Although Democrat members of the committee agreed with Republicans’ demand to hold fraudsters accountable, some Democrats pivoted away from the issue of fraud. They said the committee ought to instead focus on U.S. Immigration and Customs Enforcement actions in Minnesota, where confrontations twice turned deadly in January. Here are four takeaways. Payments ‘Kept Flowing’ After Fraud Alarms Walz has said that his administration acted quickly, but Comer said that claim “does not hold up to the facts.” Even after fraud was “known, documented, and repeatedly broug...
In this podcast, Motley Fool contributors Tyler Crowe, Matt Frankel, and Jon Quast discuss: Nvidia 's earnings. 's earnings. The evolving landscape for CPUs and GPUs. The bull vs. bear look at MercadoLibre 's earnings. 's earnings. The Trade Desk's quarterly results. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out ...
In this podcast, Motley Fool contributors Tyler Crowe, Matt Frankel, and Jon Quast discuss: Nvidia 's earnings. 's earnings. The evolving landscape for CPUs and GPUs. The bull vs. bear look at MercadoLibre 's earnings. 's earnings. The Trade Desk's quarterly results. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » A full transcript is below. Should you buy stock in Nvidia right now? Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $534,817!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,123,912!* Now, it’s worth noting Stock Advisor’s total average return is 964% — a market-crushing outperformance compared to 192% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors. See the 10 stocks » *Stock Advisor returns as of March 6, 2026. This podcast was recorded on Feb. 26, 2026. Tyler Crowe: Come on. You knew we were going to talk about NVIDIA earnings. This is Motley Fool Money. Welcome to Motley Fool Money. I'm Tyler Crowe, and today I'm joined by longtime Fool contributors Matt Frankel and Jon Quast. Earnings are still the topic of the week, and some investor favorites are certainly rep...
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Interactive Brokers Chief Strategist Steve Sosnick, Cleveland Fed President Beth Hammack, Rosenblatt Securities’ Barton Crockett, Council on Foreign Relations Senior Fellow Elliott Abrams, Gabelli Funds’ John Belton, Evercore ...
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Interactive Brokers Chief Strategist Steve Sosnick, Cleveland Fed President Beth Hammack, Rosenblatt Securities’ Barton Crockett, Council on Foreign Relations Senior Fellow Elliott Abrams, Gabelli Funds’ John Belton, Evercore ISI’s Julian Emanuel, Eurasia Group President & Founder Ian Bremmer, Pipeline Equity CEO Katica Roy, and Bezel CEO Quaid Walker. (Source: Bloomberg)
The S&P 500 Index ($SPX) (SPY) on Friday closed down -1.33%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -0.95%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -1.51%. March E-mini S&P futures (ESH26) fell -1.39%, and March E-mini Nasdaq futures (NQH26) fell -1.58%. Stock indexes fell sharply on Friday, with the Dow Jones Industrial Average posting a 3.5-month low amid concern t...
The S&P 500 Index ($SPX) (SPY) on Friday closed down -1.33%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -0.95%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -1.51%. March E-mini S&P futures (ESH26) fell -1.39%, and March E-mini Nasdaq futures (NQH26) fell -1.58%. Stock indexes fell sharply on Friday, with the Dow Jones Industrial Average posting a 3.5-month low amid concern that the war in the Middle East will keep pushing energy prices higher, sparking inflation. Qatar’s energy minister told the Financial Times on Friday that the war in the Middle East could “bring down the economies of the world,” and predicted that all Gulf energy exporters would shut down production within weeks if the war drags on, driving crude oil prices to $150 a barrel. Join 200K+ Subscribers: Stock losses accelerated on Friday on comments from President Trump, who said the US doesn’t want to negotiate an end to the war with Iran, and that “there will be no deal with Iran except unconditional surrender,” fueling concerns the US may be girding for an extended conflict. Stocks also retreated on Friday after US employers unexpectedly cut jobs last month and the unemployment rate rose, raising doubts about the health of the labor market. US Feb nonfarm payrolls unexpectedly fell by -92,000, weaker than expectations of a +55,000 increase and the biggest decline in four months. The Feb unemployment rate unexpectedly rose +0.1 to 4.4%, showing a weaker labor market than expectations of no change at 4.3%. US Feb average hourly earnings rose +0.4% m/m and +3.8% y/y, stronger than expectations of +0.3% m/m and +3.7% y/y. US Jan retail sales fell -0.2% m/m, a smaller decline than expectations of -0.3% m/m, Jan retail sales ex-autos were unchanged m/m, right on expectations. US Jan consumer credit rose by +$8.05 billion, weaker than expectations of +$12.65 billion. Fed Governor Christopher Waller said, "Thinking about monetary policy going forward, the Iran war is unlikely to caus...
peshkov/iStock via Getty Images Thesis Summary The S&P 500’s next major move will be determined by what oil does next. After rallying over 20%, Brent crude is currently trading at nearly $90. If things got worse and we saw a spike toward $120 oil, this would likely trigger a 5-10% correction. But if the war premium fades, which I see as more likely, oil could collapse back towards $60, potentially...
peshkov/iStock via Getty Images Thesis Summary The S&P 500’s next major move will be determined by what oil does next. After rallying over 20%, Brent crude is currently trading at nearly $90. If things got worse and we saw a spike toward $120 oil, this would likely trigger a 5-10% correction. But if the war premium fades, which I see as more likely, oil could collapse back towards $60, potentially igniting the next leg of the AI bull market. Let’s lay out the key scenarios below. Oil Prices Matter Again For almost a year now, it has seemed like oil was a non-issue. Prices had been stable and subdued for over a year. And then something changed in 2026. Energy began to outperform all other sectors in the market, and now, with the breakout of the Iran war, oil is up 20% in a week. The narrative-driven AI bull market has suddenly been confronted with a new narrative: the oil crisis. It’s a simple and compelling story. Higher oil leads to higher inflation, potentially higher bond yields, and lower equity multiples. Or it can even lead to out-and-out stagflation like in the 70s. But the situation today is very different from what it was 50 years ago. The Oil Market Is Fighting Two Opposite Forces The oil market right now is being pulled in two completely opposite directions. On one hand, the current war in Iran is disrupting the supply of oil, or perhaps more accurately, the distribution. The problem isn't oil production, but rather that one of the main distribution lanes, the Strait of Hormuz, is no longer safe. Consider that roughly 20% of global oil consumption travels across this channel daily. Major banks like JP Morgan ( JPM ) have already modelled scenarios where Brent crude surges toward $120–$125 per barrel But underneath the, yes, very real geopolitical fear, the oil market is actually experiencing a supply boom. Oil Is Oversupplied Outside of OPEC, global oil production is exploding. Countries such as t he United States , Brazil, and Guyana are all producing at...
Oracle and OpenAI have scrapped plans to expand a flagship artificial intelligence data center in Texas after negotiations dragged over financing and OpenAI’s changing needs. The collapsed talks created an opening for Meta Platforms Inc. to step in and consider leasing the planned expansion site in Abilene, Texas, from developer Crusoe, according to people familiar with the matter. Nvidia Corp., t...
Oracle and OpenAI have scrapped plans to expand a flagship artificial intelligence data center in Texas after negotiations dragged over financing and OpenAI’s changing needs. The collapsed talks created an opening for Meta Platforms Inc. to step in and consider leasing the planned expansion site in Abilene, Texas, from developer Crusoe, according to people familiar with the matter. Nvidia Corp., the leading AI chipmaker, helped facilitate Meta’s discussions with the developer, said the people, who asked not to be identified because the talks are private. The shifting plans underscore the complexity of building out AI data centers, which are expected to cost in the tens of billions of dollars and require cooperation from a wide swath of partners. Bloomberg Tech Co-Host Ed Ludlow joins Bloomberg Businessweek Daily to discuss. He speaks with Carol Massar and Tim Stenovec. (Source: Bloomberg)
The Food and Drug Administration’s embattled vaccine chief, Dr Vinay Prasad, is once again leaving the agency – the second time in less than a year that he’s departed after decisions involving the review of vaccinations and specialty drugs for rare diseases. FDA commissioner Marty Makary announced the news to FDA staff in an email late Friday, saying Prasad would depart at the end of April. Makary...
The Food and Drug Administration’s embattled vaccine chief, Dr Vinay Prasad, is once again leaving the agency – the second time in less than a year that he’s departed after decisions involving the review of vaccinations and specialty drugs for rare diseases. FDA commissioner Marty Makary announced the news to FDA staff in an email late Friday, saying Prasad would depart at the end of April. Makary said Prasad would return to his academic job at the University of California, San Francisco. Prasad’s latest ouster follows a string of high-profile controversies involving the FDA’s review of vaccines, gene therapies and biotech drugs in which companies have criticized the agency for reversing itself, in some cases calling for new trials of products previously greenlighted by regulators. In July, Prasad was briefly forced from his job after running afoul of biotech executives, patient groups and conservative allies of Donald Trump. He was reinstated less than two weeks later with the backing of health secretary Robert F Kennedy Jr and Makary. A longtime academic and critic of the FDA’s standards for drug reviews, Prasad has taken a seemingly contradictory approach to regulation since arriving at the FDA last May. On repeated occasions, Prasad has joined Makary in announcing steps to make FDA drug reviews faster and easier for companies. But he also has imposed new warnings and study requirements for some biotech drugs and vaccines, particularly Covid shots that have long been a target for Kennedy, a longtime anti-vaccine activist before joining the Trump administration.
Shenzhen is one of Asia’s top tech hubs, while Hong Kong has long been a financial powerhouse. Together, they are two souls merging into a turbocharged engine of growth behind the Greater Bay Area. The government’s flagship project, the Northern Metropolis, will soon become a focal point of this unbeatable combination. At its heart will be a supercomputing facility to help the city become a data c...
Shenzhen is one of Asia’s top tech hubs, while Hong Kong has long been a financial powerhouse. Together, they are two souls merging into a turbocharged engine of growth behind the Greater Bay Area. The government’s flagship project, the Northern Metropolis, will soon become a focal point of this unbeatable combination. At its heart will be a supercomputing facility to help the city become a data centre hub. Range Intelligent Computing Technology won the tender to build the supercomputing centre by investing HK$23.8 billion (US$3 billion) over three years. When fully operational, the centre is projected to boost Hong Kong’s computing power 36-fold. The firm’s parent, Shenzhen-listed Runze Intelligent Computing Technology Group, specialises in developing and operating high-end data centres – the kind of facility needed to power advanced artificial intelligence and supercomputing. It has built about 20 data facilities across the country. Advertisement Hong Kong is positioning itself at the forefront of the nation’s quest for computing supremacy. The new facility will occupy 11 hectares (27 acres) of land in the northern New Territories, right across from Shenzhen. The high engineering complexity in the project’s construction will boost the professional training of a new generation of local engineers and technicians. Such facilities are notorious for consuming power, but CLP Power, which serves the New Territories with its power grids, is working closely with the project. This is a good example of public-private cooperation to enhance hi-tech innovation. Since Hong Kong has an official cap on electricity charges, any extra power demand will not affect the utility bills of nearby households. Advertisement The company is well qualified for the task, but as this megaproject concerns the city’s tech future, the government has a duty to closely monitor each stage of development to ensure steady progress.
In the latest close session, Dow Inc. (DOW) was down 1.3% at $33.28. This move was narrower than the S&P 500's daily loss of 1.33%. Elsewhere, the Dow lost 0.95%, while the tech-heavy Nasdaq lost 1.59%. Coming into today, shares of the materials science had gained 10.2% in the past month. In that same time, the Basic Materials sector gained 4.43%, while the S&P 500 gained 0.58%. Market participant...
In the latest close session, Dow Inc. (DOW) was down 1.3% at $33.28. This move was narrower than the S&P 500's daily loss of 1.33%. Elsewhere, the Dow lost 0.95%, while the tech-heavy Nasdaq lost 1.59%. Coming into today, shares of the materials science had gained 10.2% in the past month. In that same time, the Basic Materials sector gained 4.43%, while the S&P 500 gained 0.58%. Market participants will be closely following the financial results of Dow Inc. in its upcoming release. The company is forecasted to report an EPS of -$0.35, showcasing a 1850% downward movement from the corresponding quarter of the prior year. Meanwhile, our latest consensus estimate is calling for revenue of $9.44 billion, down 9.49% from the prior-year quarter. For the annual period, the Zacks Consensus Estimates anticipate earnings of -$0.15 per share and a revenue of $39.24 billion, signifying shifts of +84.04% and -1.81%, respectively, from the last year. Investors should also take note of any recent adjustments to analyst estimates for Dow Inc. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability. Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, there's been a 6.75% fall in the Zacks Consensus EPS estimate. Right now, Dow Inc. possesses a Zacks Rank of #3 (Hold). The Chemical - Diversified industry is part of the Basic Materials sector. Currently, this industry holds a Zacks Industry Rank of 201, positioning it in the b...
Getty Images Intro When Novo Nordisk A/S ( NVO ) CEO Maziar "Mike" Doustdar and Eli Lilly and Company ( LLY ) CEO David Ricks stood shoulder to shoulder in the White House Oval Office during their drug pricing deal ‑announcement ceremony with the Trump administration back in November, they came across almost like close allies fighting for the very same goal. On that day, the two men helped cement ...
Getty Images Intro When Novo Nordisk A/S ( NVO ) CEO Maziar "Mike" Doustdar and Eli Lilly and Company ( LLY ) CEO David Ricks stood shoulder to shoulder in the White House Oval Office during their drug pricing deal ‑announcement ceremony with the Trump administration back in November, they came across almost like close allies fighting for the very same goal. On that day, the two men helped cement the future landscape for the pricing and accessibility of weight‑loss medications. Moreover, the event likely laid the groundwork for better health outcomes for Americans by supporting healthier weights and lifestyles. Business leaders around the world spend a great deal of effort crafting inspiring mission statements. Yet the kind of foundation that Novo and Lilly laid with that White House event is so powerful that it’s hard to imagine anything better to serve as a great mission. While companies may come up with big and inspiring mission statements, everyday business reality is tough — any mistake a competitor makes is used right away to gain ground on each other. In sports, the winner is usually determined in a simple and obvious way — someone runs faster, or one team scores more points than the other. In business, however, identifying the winner can be far more complicated. Leadership can shift within months or even weeks, and in many cases, it’s not clear at all who is actually racing ahead. Great business leaders rely on dozens of essential skills to succeed, and adaptability is certainly one of the most important. One must be able to stand shoulder‑to‑shoulder with their biggest rival in a friendly ceremony one moment, and the next moment fight a tough, unforgiving battle for market leadership with the very same person whose hand they just shook and with whom they exchanged friendly, pleasant words. If business leadership can be compared to any sport, in my view, the closest match could be chess. Every move can change the entire board, opening countless new possibili...